Celgene Corp (NASDAQ:CELG)

U.S. Markets are not yet open, but CELG is being traded in the pre-market session. Pre-Market quote »
118.68
Delayed Data
As of Mar 27
 +1.02 / +0.87%
Today’s Change
66.85
Today|||52-Week Range
129.06
+6.10%
Year-to-Date

Today’s Trading

Previous close117.66
Today’s open118.11
Day’s range-- - --
Volume5,510,401
Average volume (3 months)5,398,315
Market cap$95.0B
Dividend yield--
Data as of 03/27/2015

Growth & Valuation

Earnings growth (last year)+41.84%
Earnings growth (this year)+29.90%
Earnings growth (next 5 years)+24.17%
Revenue growth (last year)+17.89%
P/E ratio49.6
Price/Sales11.75
Price/Book14.55

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+0.38+0.66%
AZNAstraZeneca+0.30+0.43%
LLYEli Lilly and Co+0.14+0.19%
BMYBristol-Myers Squibb+0.26+0.40%
Data as of 03/27/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$1.06
Annual revenue (last year)$7.6B
Annual profit (last year)$2.0B
Net profit margin26.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account